Dear Mr. Trump, First, I would like to apologize for all the insightful and well-informed things I have written about you. But please keep in mind the context in which those remarks were made. Honestly, I think you're tremendous. Tremendous. I love you. You are an imbecile, it's true. But at least you are not a conniving, power-grasping, finger-pointing harpy. You at....more>>>
bluebird bio, (NASDAQ:BLUE) is one of the oncology immunotherapy stocks I mentioned recently as worth a good look, (article titled ‘Immunotherapy Over Reaction’, a basic primer to the immunotherapy subsector and its ETF). BLUE is also a recent Cramer pick. Immunotherapy stocks have been hit hard over the summer but BLUE is a relatively highly valued genetic specialist, with some interesting....more>>>
Shares of Halliburton (HAL) and Baker Hughes (BHI) are soaring after they announced that they’d challenge the U.S. Department of Justice’s decision to block their merger. RBC’s Kurt Hallead has the details:
Shares of both companies rose ~5% following the joint press release indicating they would challenge the DoJ’s decision to oppose....more>>>
President-elect Donald Trump warns he’ll impose big tariffs on goods from Mexico to protect blue collar jobs in America.
But Trump may want to take note of how similar tariffs have played out in Argentina. In 2009, that country put a 35% tariff on computers, tablets and other electronics in order to shield its manufacturing workers. It’s the same size as Trump’s proposed....more>>>
Strategas Research Partners’ Jason DeSena Trennert and Ryan Grabinski wonder what impact Valeant Pharmaceuticals International’s (VRX) current woes will have on other so-called platform companies,Endo International (ENDP), Allergan (AGN), and Danaher (DHR) among them:
Valeant’s recent difficulties might warrant a second look at platform companies…We dont mean to pile....more>>>